Phase II Study of Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydroxychloroquine (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 14 Jun 2017 Biomarkers information updated
- 14 May 2013 Planned End Date changed from 1 Dec 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 14 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.